[1]
Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 2018; 7(1): 501.
[8]
Brodie A, Tovia-Brodie O, Ofran Y. Large scale analysis of phenotype-pathway relationships based on GWAS results. PLoS One 2014; 9(7)e100887
[13]
Karp PD, Paley S, Romero P. The pathway tools software. Bioinformatics 2002; 18(1): 225-32.
[18]
Michael PC. Pathway information for systems biology. Febs Lett 2005; 579(8): 1815-20.
[20]
Robert LY, Settleman J. Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis. Curr Opin Genet Dev 2012; 22(1): 45-9.
[21]
Henderson-Maclennan Nicole K, et al. Pathway analysis software: annotation errors and solutions. Mol Genet Metab 2010; 2(3): 135-40.
[23]
Kim JH. Network biology, sequence, pathway and ontology informatics. Genome Data Analysis 2019; 2019: 175-87.
[24]
Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016; 44: 457-62.
[26]
Kamburov A, Wierling C, Lehrach H, Herwig R. “ConsensusPathDB--a database for integrating human functional interaction networks.” Nucleic Acids Research 37. Database (Oxford) 2009; 2009: D623-8.
[31]
Ethan GC, Gross BE, Demir E, et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res 2011; 39(Database issue): 685-90.
[32]
Croft D, Jupe S, Mattews L, et al. The Reactome pathway knowledgebase. Nucleic Acids Res 2014; 42(Database issue): 472-7.
[38]
Kandasamy K, Mohan SS, Raju R, et al. NetPath: a public resource of curated signal transduction pathways. Genome Biol 2010.
[41]
Simo EM, Sinigaglia M, Bugs CA, et al. Induced genome maintenance pathways in pre-cancer tissues describe an anti-cancer barrier in tumor development. Mol Biosyst 2012; 8(11): 3003.
[43]
Gough NR. Science’s Signal Transduction Knowledge Environment. Annals of the New York Academy of Sciences 2002; 971(1): 585-7.
[51]
Barel Gal. Network and Pathway Analysis of Toxicogenomics Data. Front Genet 2018.
[53]
Schaefer CF, Anthony K, Krupa S, et al. PID: the pathway interaction databaseNucleic Acids Res 2009.37(Database): 674-9.
[58]
Krupa S, Anthony K, Buchoff JR, Day M. Abstract LB-130: The NCI-Nature Pathway Interaction Database: A cell signaling resource. Cancer Res 2007; 70(8)(Suppl.).
[61]
Chowdhury S, Sarkar RR. Comparison of human cell signaling
pathway databases--evolution, drawbacks and challenges. Database
(Oxford) 2015.
[74]
FAIRsharingorg IPAVS; Integrated Pathway Analysis and Visualization System 2019.
[78]
Atanas K, Christoph W, Hans L, Ralf H. Consensuspathdb—a database for integrating human functional interaction networks.Nucleic Acids Res 2009; 37(suppl_1): D623-D628..
[79]
Reimand J. Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and Enrichment Map. Nat Protoc 2019; 14(2): 482-517.
[82]
Gray KA, Yates B, Seal LR, Wright MW, Bruford EA. Genenames.org: the HGNC resources in 2015. Nucleic Acids Res 2015; 43(D1): D1079-85.
[83]
Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez gene: Gene-centered information at NCBI. Nucleic Acids Res 2004; 33(Database issue): D54-8.
[87]
Ivan YI, Vorsanova SG, Yurov YB. Pathway-based classification of genetic diseases. Mol Cytogenet 2019; 12(1): 4.
[89]
Turnpenny PD, Ellard S. Emery’s elements of medical genetics. 15th ed. E-book. Elsevier Health Sciences 2016.
[92]
List M, Alcaraz N, Batra R. De Novo Pathway-Based Classification of Breast Cancer SubtypesProtein-Protein Interaction Networks Methods in Molecular Biology. New York, NY: Humana 2020; Vol. 2074.
[93]
Heng HH, Regan S. A systems biology perspective on molecular cytogenetics. Curr Bioinform 2017; 12(1): 4-10.
[95]
Li Y, Agarwal P. A pathway-based view of human diseases and disease relationships. PLoS One 2009; 4(2)e4346
[96]
Zhilong M, Binghui G, Ziqiao Y, Jiahui L, Zhiming Z. Disease classification via gene network integrating modules and pathways. R Soc Open Sci 2019; 6(7)190214
[98]
Kim Y-A, Wuchty S, Przytycka TM. Identifying causal genes and dysregulated pathways in complex diseases. PLOS Comput Biol 2011; 7(3)e1001095
[99]
Culf-Cuperlovic M. Machine learning methods for analysis of metabolic data and metabolic pathway modeling. Metabolites 2018; 8(1): 4.